Mycobacteria
Carbon-limited M bovis BCG cells subject to growth rate-dependent control
Published in TB and Outbreaks Week, May 17th, 2005
"An experimental system of Mycobacterium tuberculosis growth in a carbon-limited chemostat has been established by the use of Mycobacterium bovis BCG as a model organism. For this model, carbon-limited chemostats with low concentrations of glycerol were used to simulate possible growth rates during different stages of tuberculosis," researchers in England report.
"A doubling time of 23 hours (D=0.03 h-1) was adopted to represent cells during the acute phase of infection, whereas a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Hemorrhagic Conjunctivitis Outbreaks
Hemorrhagic conjunctivitis outbreak caused by coxsackievirus A24 variant - Norovirus Outbreaks
Gastroenteritis outbreak spread attributable to single norovirus strain - Salmonella Outbreaks
S. enterica producing CTX-M-27 ESBL causes nosocomial outbreak - Shistosomiasis
S. mansoni infection increases susceptibility to M. bovis BCG infection - Tuberculosis Outbreaks
M. bovis cause of two nosocomial multidrug-resistant TB outbreaks in Spain - Acute Lymphoblastic Leukemia
RAS mutation associated with hyperdiploidy/parental characteristics in ALL - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
